TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · MEDICAL DEVICES
$83.62
+7.18% today
Updated 2026-10-28
Market cap
$9.10B
P/E ratio
—
P/S ratio
14.75x
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$12 – $103
Volume
3.4M
10X Genomics Inc (TXG) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$83.62
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$56.05
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.5B | $0.5B | $0.6B | $0.6B | $0.6B | $0.7B | $0.9B | $1.0B | $1.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 16.55% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -12.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.